Rockwell Medical (RMTI) Tops Q3 EPS by 5c, provides guidance
Tweet
Share
E-mailGet Alerts RMTI Hot Sheet
Price: $7.49 +1.08%
Financial Fact:
Diluted Earnings (Loss) per Share: -0.09
Today's EPS Names:
MSGM, SMID, VISL, More
Financial Fact:
Diluted Earnings (Loss) per Share: -0.09
Today's EPS Names:
MSGM, SMID, VISL, More
Join SI Premium – FREE
Rockwell Medical (NASDAQ: RMTI) reported Q3 EPS of $0.00, $0.05 better than the analyst estimate of ($0.05). Revenue for the quarter came in at $15.9 million versus the consensus estimate of $16.18 million.
GUIDANCE:
Rockwell Medical sees FY2025 revenue of $65-70 million, versus the consensus of $68.374 million.
For earnings history and earnings-related data on Rockwell Medical (RMTI) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- DocGo (DCGO) Misses Q2 EPS by 6c; Offers Guidance
- Barclays Upgrades Schott Pharma AG (1SXP:GR) to Overweight
- Duos Technologies Group, Inc. (DUOT) Tops Q2 EPS by 163c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
